Safety monitoring of a new pentavalent vaccine in the expanded programme on immunisation in Ghana

Drug Safety

Volumn 30, Issue 4, 2007, Pages 347-356

  Dodoo, Alexander N O ^a   Renner, Lorna ^a   Van Grootheest, Adrianus C ^b   Labadie, Jerry ^b   Antwi Agyei, Kwadwo O ^c   Hayibor, Selasie ^a   Addison, Johannes ^a   Pappoe, Victoria ^a   Appiah Danquah, Augustina ^a  

^a UNIVERSITY OF GHANA   (Ghana)

^b Netherlands Pharmacovigilance Centre Lareb's Hertogenbosch   (Netherlands)

^c GHANA HEALTH SERVICE   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; AMOXICILLIN; BACTERIAL VACCINE; CHLORAMPHENICOL; CLOXACILLIN; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; FLUCLOXACILLIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PARACETAMOL; PENICILLIN G; TRITANIX; UNCLASSIFIED DRUG;

APPETITE DISORDER; ARTICLE; BREATHING DISORDER; BRONCHOPNEUMONIA; COMMON COLD; CONTROLLED STUDY; COUGHING; CRYING; DIARRHEA; DIPHTHERIA; DISEASE SEVERITY; DRUG ERUPTION; DRUG FEVER; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EAR DISCHARGE; EAR DISEASE; EYE DISCHARGE; FEMALE; FOLLOW UP; GASTROENTERITIS; GHANA; HEALTH CENTER; HEPATITIS B; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INFLUENZA; INFORMED CONSENT; INJECTION SITE ABSCESS; INJECTION SITE SWELLING; INTERVIEW; IRRITABILITY; LIMB PAIN; MAJOR CLINICAL STUDY; MALARIA; MALE; MEDICAL CARE; MOUTH PAIN; NASAL DISCHARGE; NOSE DISEASE; OTALGIA; OUTPATIENT DEPARTMENT; PARENT; PERTUSSIS; PHYSICIAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECORDING; RHINITIS; SIDE EFFECT; SKIN ABSCESS; SKIN INFECTION; TEACHING HOSPITAL; TETANUS; VOMITING; WEIGHT REDUCTION;

EID: 34247246318     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200730040-00007     Document Type: Article

References (16)

1. Hinman AR. Global progress in infectious disease control. Vaccine 1998 Jul; 16 (11-12): 1116-21
2. Darwish A, Roth CE, Duclos P, et al. Investigation into a cluster of infant deaths following immunization: evidence for methanol intoxication. Vaccine 2002; 20 (29-30): 3585-9
3. Francois G, Duclos P, Margolis H, et al. Vaccine safety controversies and the future of vaccination programs. Pediatr Infect Dis J 2005; 24 (11): 953-61
4. Mehta U, Milstien JB, Duclos P, et al. Developing a national system for dealing with adverse events following immunization. Bull World Health Organ 2000; 78 (2): 170-7
5. Clements, CJ, editor. Supplementary information on vaccine safety. Part 2: background rates of adverse events following immunization. Geneva: WHO, 2000
6. Santos JI, Martin A, De Leon T, et al. DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children. Vaccine 2002 March 15; 20 (13-14): 1887-93
7. Aristegui J, Usonis V, Coovadia H, et al. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis 2003; 7 (2): 143-51
8. Aristegui J, Dal-Re R, Diez-Delgado J, et al. Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugated vaccine and administered in two simultaneous injections to infants at 2, 4 and 6 months of age. Vaccine 2003; 21 (25-26): 3593-600
9. Tregnaghi M, Lopez P, Rocha C, et al. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America. Rev Panam Salud Publica 2006; 19 (3): 179-88
10. DeStefano F, Thompson WW. MMR vaccine and autism: an update of the scientific evidence. Expert Rev Vaccines 2004; 3 (1): 19-22
11. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf 1994; 10: 93-102
12. Yeh SH, Ward JI, Partridge S, et al. Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infants. Pediatr Infect Dis J 2001; 20 (10): 973-80
13. Carlsson RM, Claesson BA, Selstam U, et al. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age. Pediatr Infect Dis J 1988; 17 (11): 1026-33
14. Nolan T, Hogg G, Darcy M-A, et al. A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicity. Vaccine 2001; 19: 2127-37
15. Klinkenberg E, McCall PJ, Wilson MD, et al. Urban malaria and anaemia in children: a cross-sectional survey in two cities of Ghana. Trop Med Int Health 2006; 11 (5): 578-88
16. Browne ENL, Bonney AA, Agyapong FA, et al. Factors influencing participation in national immunization days in Kumasi, Ghana. Annals of Trop Med Parasitol 2002; 96 (1): 93-104